• Angiotensin Peptides Enhance SARS-CoV-2 Spike–AXL Binding

  2026-06-29

  Oliveira et al. (2025) reveal that naturally occurring angiotensin peptides, including N-terminally truncated fragments, robustly increase SARS-CoV-2 spike protein binding to cellular receptors—especially AXL. This mechanistic insight advances understanding of how renin–angiotensin system peptides may modulate viral entry and highlights new angles for infectious disease research.

• Fingolimod (FTY720): Optimizing Immune Modulation in Tumor R

  2026-06-29

  Fingolimod (FTY720) uniquely bridges lymphocyte egress inhibition and neuroprotection, making it a powerful tool for advanced immunotherapy research. This guide details best practices for integrating Fingolimod into in vivo and in vitro experimental workflows, troubleshooting, and leveraging its synergy with next-generation immune cell engineering.

• Faropenem Sodium: Broad-Spectrum Penem Antibiotic Insights

  2026-06-28

  Faropenem sodium is a non-classical penem antibiotic notable for its inhibition of bacterial cell wall synthesis and robust action against Gram-positive, Gram-negative, and anaerobic bacteria. Its oral bioavailability and β-lactamase stability support its use in antimicrobial and resistance research, though regulatory and resistance concerns shape its application landscape.

• Foretinib (GSK1363089): Quantitative Insights in Tumor Cell

  2026-06-27

  Explore how Foretinib (GSK1363089) enables nuanced, quantitative analysis of tumor cell growth inhibition and cell death in modern cancer research. This article applies rigorous in vitro methodology to maximize reproducibility and translational value.

• 2-Hydroxypropyl-β-cyclodextrin: Technical Guidance for Solub

  2026-06-26

  2-Hydroxypropyl-β-cyclodextrin addresses the persistent challenge of incorporating poorly water-soluble, hydrophobic compounds—especially those with aromatic or phenyl groups—into aqueous pharmaceutical and biochemical workflows. Use is validated for drug formulation excipient and solubility enhancement only; applications outside these domains are not supported by current documentation.

• I-BET-762: BET Inhibition Driving Ferroptosis and Inflammati

  2026-06-26

  This thought-leadership article explores the mechanistic underpinnings and translational potential of the BET inhibitor I-BET-762 in cancer and inflammation research. Synthesizing recent mechanistic findings with strategic research guidance, it highlights I-BET-762’s role in modulating ferroptosis and LPS-inducible gene expression, provides protocol recommendations, and situates the compound within the rapidly evolving landscape of targeted epigenetic therapeutics.

• Sulfamonomethoxine (SMM): Mechanisms, Biotransformation, and

  2026-06-25

  Explore the advanced mechanisms and environmental biotransformation of Sulfamonomethoxine (SMM), a leading veterinary antibiotic. This article delivers a unique, science-driven perspective on SMM’s molecular action, environmental fate, and best practices for responsible use—expanding beyond standard protocols to guide informed laboratory and field decisions.

• Synergistic Induction of Cell Death in Renal Cancer via SGI-

  2026-06-25

  The reference study demonstrates that combining the DNMT1 inhibitor SGI-1027 with everolimus overcomes resistance in renal cell carcinoma by triggering both apoptosis and GSDME-dependent pyroptosis through lysosomal membrane permeability. This dual-target strategy offers new therapeutic insights for advanced RCC and highlights translational opportunities for overcoming drug resistance.

• WAY-100635: Advancing Serotonin Antagonist Research in Pain

  2026-06-24

  Explore how WAY-100635, a potent and selective 5-HT1A receptor antagonist, is transforming translational neuroscience and pain research. This article blends mechanistic insights with actionable protocol advice, highlighting the compound’s pivotal role in dissecting serotonergic circuits that govern both sensory and affective pain dimensions, with direct relevance to cannabinoid-serotonin interplay and imaging strategies.

• Transmission Dynamics of Carbapenemase Genes in CREC, Guangd

  2026-06-23

  This study delivers a detailed molecular and epidemiological analysis of carbapenemase-encoding gene (CEG) transmission in carbapenem-resistant Enterobacter cloacae (CREC) from eight hospitals in Guangdong, China, during the COVID-19 pandemic. The findings highlight the dominant role of plasmid-borne blaNDM-1 in multidrug resistance and provide crucial insights for antimicrobial resistance surveillance and infection control.

• Alcian Blue & Nuclear Fast Red Staining Kit, pH2.5: Evidence

  2026-06-23

  The Alcian Blue & Nuclear Fast Red Staining Kit, pH2.5 enables precise histological staining of acid mucopolysaccharides and nuclei, supporting chondrogenic differentiation and mucin detection workflows. This article reviews the biological rationale, validated mechanisms, practical protocol parameters, and evidence benchmarks for the APExBIO kit, clarifying its research applications and limitations.

• PBS Liposomes: Precision Controls for Macrophage Depletion A

  2026-06-22

  PBS Liposomes provide a gold-standard, biologically inert control for macrophage depletion studies, enabling researchers to distinguish true clodronate-mediated effects from baseline phagocytosis. Their stability and reproducibility streamline in vivo workflows, ensuring rigorous immunology and neurobiology assays.

• Decoding Hepatic Uptake of PEGylated Iron Oxide Nanoparticle

  2026-06-22

  This study systematically dissects how the size and PEGylation of iron oxide nanoparticles dictate their uptake by distinct hepatic cell types, overturning the traditional view that Kupffer cells dominate nanoparticle clearance. The findings provide actionable parameters for designing nanomedicines with improved specificity and reduced off-target hepatic accumulation.

• Sulfachloropyridazine in Microbiome and Infection Research

  2026-06-21

  Sulfachloropyridazine empowers researchers to dissect bacterial folate synthesis and model microbiome shifts during infection or antibiotic exposure. Its unique integration in enzyme inhibition assays and in vivo infection models, combined with robust troubleshooting strategies, sets it apart as an indispensable research tool.

• Nitrocefin Chromogenic Cephalosporin Substrate in β-Lactamas

  2026-06-20

  Nitrocefin enables rapid, visual detection of β-lactamase activity for high-throughput antibiotic resistance profiling and inhibitor screening. Its vivid colorimetric response and robust workflow adaptability give researchers reproducibility and sensitivity across clinical and experimental microbiology applications.

450 records 13/30 page Previous Next First page 上5页 1112131415 下5页 Last page